GO
Loading...

Enter multiple symbols separated by commas

Obamacare

More

Health Care

  • Biotech

    Jon Najarian, co-founder of OptionMonster.com, breaks down a worrisome trend in the stock market right now.

  • An associate scientist at Gilead Sciences.

    Sales of the novel hepatitis C drugs Sovaldi and Harvoni helped the company top Wall Street estimates.

  • Traders work on the floor of the New York Stock Exchange.

    Traders are watching the iShares Nasdaq Biotechnology ETF for clues on whether a deeper market decline is on the horizon.

Politics

White House